Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Open-label Phase 1b Study of Doxorubicin-based Chemotherapy Regimens, With and Without Sildenafil, With Exploratory Analysis of Intermediate Cardiac Markers

NCT01375699 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01375699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01375699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Open-label Phase 1b Study of Doxorubicin-based Chemotherapy Regimens, With and Without Sildenafil, With Exploratory Analysis of Intermediate Cardiac Markers
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
August 11, 2011
Completion date
January 19, 2018
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, gastrointestinal cancer, genitourinary cancer, gynecologic cancer, sarcoma